148 related articles for article (PubMed ID: 9053533)
1. [Clinical studies on vancomycin in the treatment of MRSA infection].
Shimizu K; Orizu M; Kanno H; Kitamura S; Konishi T; Soma K; Nishitani H; Noguchi Y; Hasegawa S; Hasegawa H; Wada K
Jpn J Antibiot; 1996 Aug; 49(8):782-99. PubMed ID: 9053533
[TBL] [Abstract][Full Text] [Related]
2. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H
Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
[TBL] [Abstract][Full Text] [Related]
3. [Bacteriological evaluation of combined effects of vancomycin and beta-lactams. I. Results against methicillin-resistant Staphylococcus aureus].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 Nov; 46(11):939-45. PubMed ID: 8309069
[TBL] [Abstract][Full Text] [Related]
4. [Recent findings based on the results of the post-marketing surveillance of vancomycin hydrochloride for intravenous infusion].
Shimada K
Jpn J Antibiot; 2003 Aug; 56(4):259-71. PubMed ID: 14567250
[TBL] [Abstract][Full Text] [Related]
5. [Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus].
Shirai M; Ide K; Sato M; Murakami M; Tanaka Y; Sato A; Chida K
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1233-9. PubMed ID: 8583715
[TBL] [Abstract][Full Text] [Related]
6. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
Yamaguchi Y; Hanaki H; Yanagisawa C; Ikeda-Dantsuji Y; Hashimoto T; Yazaki H; Sugahara K; Yanagisawa T; Kawajiri H; Sato S; Ishizaki A; Tachihara-Sato R; Takahashi Y; Ono T; Kageyama Y; Kawaguchi T; Tamura A; Hagane K; Sunakawa K
J Infect Chemother; 2009 Oct; 15(5):274-8. PubMed ID: 19856063
[TBL] [Abstract][Full Text] [Related]
7. [Combined effect of vancomycin or teicoplanin plus a beta-lactam antibiotic in mouse infection models caused by beta-lactam antibiotec-induced vancomycin resistant MRSA (BIVR)].
Hatano K; Yokota Y; Hanaki H; Sunakawa K
Kansenshogaku Zasshi; 2006 May; 80(3):243-50. PubMed ID: 16780131
[TBL] [Abstract][Full Text] [Related]
8. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
Ishii T; Takayama Y; Takase Y; Orikasa Y
Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of combination therapy against MRSA in Ibaraki Prefecture].
Otsuka M; Sawahata T; Nakai T; Hasegawa S; Iwata S; Yoshizawa Y; Ishida H; Irokawa M; Goto A; Shinohara Y
Jpn J Antibiot; 1994 Jun; 47(6):781-9. PubMed ID: 8072187
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of arbekacin on MRSA infections].
Ichiyama S; Shimokata K
Jpn J Antibiot; 1994 Jun; 47(6):731-5. PubMed ID: 8072181
[TBL] [Abstract][Full Text] [Related]
11. The antagonistic effects of a combination of vancomycin and minocycline in Staphylococcus aureus with heterogeneous resistance to vancomycin.
Oshiro T; Nagasawa Z; Hanaki H; Ikeda-Dantsuji Y; Nagayama A
J Infect Chemother; 2008 Feb; 14(1):15-22. PubMed ID: 18297444
[TBL] [Abstract][Full Text] [Related]
12. [In vitro antibacterial activity of vancomycin in combination with panipenem against carbapenem-resistant MRSA].
Sato S; Miura T; Kudo Y; Kudo E; Saitoh Y; Kimpara I; Tsujino M; Kudo H
Jpn J Antibiot; 1998 Jul; 51(7):488-93. PubMed ID: 9755432
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
[TBL] [Abstract][Full Text] [Related]
14. [Effective single and combined chemotherapeutic regimens as regards to antibiotic resistance patterns of methicillin-resistant Staphylococcus aureus (MRSA) in Japan].
Watanabe A
Nihon Rinsho; 1992 May; 50(5):1060-5. PubMed ID: 1507429
[TBL] [Abstract][Full Text] [Related]
15. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection.
Hirose K; Marui A; Arai Y; Nomura T; Inoue S; Kaneda K; Kamitani T; Fujita M; Mitsuyama M; Tabata Y; Komeda M
J Vasc Surg; 2006 Aug; 44(2):377-82. PubMed ID: 16890872
[TBL] [Abstract][Full Text] [Related]
16. Bacteriological efficacy of nafcillin and vancomycin alone or combined with rifampicin or amikacin in experimental meningitis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Sato K; Lin TY; Weintrub L; Olsen K; McCracken GH
Jpn J Antibiot; 1985 Aug; 38(8):2155-62. PubMed ID: 3852897
[TBL] [Abstract][Full Text] [Related]
17. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
[TBL] [Abstract][Full Text] [Related]
18. [A study on MRSA infections and replacement of bacteria. Efficacy of vancomycin-ceftazidime combination therapy].
Matsuoka K; Nagatomi Y; Imanishi K; Matsubara M; Nakanishi I; Watanabe H
Jpn J Antibiot; 1994 Oct; 47(10):1363-8. PubMed ID: 7807696
[TBL] [Abstract][Full Text] [Related]
19. Effects of DQ-113, a new quinolone, against methicillin- and vancomycin-resistant Staphylococcus aureus-caused hematogenous pulmonary infections in mice.
Kaneko Y; Yanagihara K; Miyazaki Y; Tsukamoto K; Hirakata Y; Tomono K; Kadota J; Tashiro T; Murata I; Kohno S
Antimicrob Agents Chemother; 2003 Dec; 47(12):3694-8. PubMed ID: 14638467
[TBL] [Abstract][Full Text] [Related]
20. [In vitro combination effect of vancomycin and carbapenems against carbapenem-resistant MRSA].
Sato S; Miura T; Kudo E; Kudo Y; Saitoh Y; Kimpara I; Tsujino M; Kudo H
Jpn J Antibiot; 1997 Aug; 50(8):711-6. PubMed ID: 9339397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
